Cited 4 times in
The Haemodynamic Effects of Propranolol and Atenolol Medication on Dobutamine Infusion in Patients with Coronary Artery Obstructive Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 곽영란 | - |
dc.contributor.author | 김지영 | - |
dc.contributor.author | 송종욱 | - |
dc.contributor.author | 오영준 | - |
dc.contributor.author | 이종화 | - |
dc.contributor.author | 홍용우 | - |
dc.date.accessioned | 2017-05-04T07:27:23Z | - |
dc.date.available | 2017-05-04T07:27:23Z | - |
dc.date.issued | 2005 | - |
dc.identifier.issn | 0300-0605 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/147315 | - |
dc.description.abstract | We compared the haemodynamic effects of beta-blockers on dobutamine infusion in 60 patients undergoing coronary artery bypass graft surgery. All patients had been taking propranolol (n = 30) or atenolol (n = 30) pre-operatively for at least 1 month. After sternotomy, dobutamine was infused at 2 microg/kg per min, and the dose increased to 4 microg/kg per min and then 8 microg/kg per min, at 15-min intervals. In both groups, dobutamine infusion did not increase the cardiac index or the heart rate, but was associated with an increase in mean arterial pressure, systemic vascular resistance index and mean pulmonary arterial pressure in a dose-dependent manner. The haemodynamic responses to dobutamine infusion were similar in the two groups. We conclude that pre-operative medication with beta-blockers reduced the inotropic and chronotropic effects of dobutamine infusion. There was no difference between the modification produced by propranolol, a non-selective beta-blocker, and that produced by atenolol, a selective beta1-blocker, however. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Sage Publications | - |
dc.relation.isPartOf | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adrenergic beta-Antagonists/pharmacology | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Arteries | - |
dc.subject.MESH | Atenolol/pharmacology* | - |
dc.subject.MESH | Coronary Artery Bypass/methods | - |
dc.subject.MESH | Coronary Artery Disease/drug therapy* | - |
dc.subject.MESH | Dobutamine/administration & dosage* | - |
dc.subject.MESH | Dobutamine/pharmacology | - |
dc.subject.MESH | Dose-Response Relationship, Drug | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Heart Rate | - |
dc.subject.MESH | Hemodynamics | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Propranolol/pharmacology* | - |
dc.subject.MESH | Time Factors | - |
dc.title | The Haemodynamic Effects of Propranolol and Atenolol Medication on Dobutamine Infusion in Patients with Coronary Artery Obstructive Disease | - |
dc.type | Article | - |
dc.publisher.location | England | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.department | Dept. of Anesthesiology and Pain Medicine (마취통증의학교실) | - |
dc.contributor.googleauthor | YJ OH | - |
dc.contributor.googleauthor | JH LEE | - |
dc.contributor.googleauthor | JY KIM | - |
dc.contributor.googleauthor | JW SONG | - |
dc.contributor.googleauthor | YW HONG | - |
dc.contributor.googleauthor | YL KWAK | - |
dc.identifier.doi | 10.1177/147323000503300308 | - |
dc.contributor.localId | A00172 | - |
dc.contributor.localId | A00977 | - |
dc.contributor.localId | A02060 | - |
dc.contributor.localId | A02389 | - |
dc.contributor.localId | A03154 | - |
dc.contributor.localId | A04420 | - |
dc.relation.journalcode | J01462 | - |
dc.identifier.eissn | 1473-2300 | - |
dc.identifier.pmid | 15938594 | - |
dc.identifier.url | http://imr.sagepub.com/content/33/3/329.long | - |
dc.subject.keyword | Atenolol | - |
dc.subject.keyword | Propranolol | - |
dc.subject.keyword | Dobutamine | - |
dc.subject.keyword | Coronary artery obstructive disease | - |
dc.contributor.alternativeName | Kwak, Young Lan | - |
dc.contributor.alternativeName | Kim, Ji Young | - |
dc.contributor.alternativeName | Song, Jong Wook | - |
dc.contributor.alternativeName | Oh, Young Jun | - |
dc.contributor.alternativeName | Lee, Jong Wha | - |
dc.contributor.alternativeName | Hong, Yong Woo | - |
dc.citation.volume | 33 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 329 | - |
dc.citation.endPage | 336 | - |
dc.identifier.bibliographicCitation | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, Vol.33(3) : 329-336, 2005 | - |
dc.date.modified | 2017-05-04 | - |
dc.identifier.rimsid | 48487 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.